USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Vital Signs - Oral Drug Delivery: Hurdles in Oral Product Development and the Need for Continued Technology Investment
Vital Signs - Oral Drug Delivery: Hurdles in Oral Product Development and the Need for Continued Technology Investment
RELEASE DATE
25-Feb-2008
25-Feb-2008
REGION
North America
North America
Research Code: 9561-00-56-00-00
SKU: HC00517-NA-MR_03989
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00517-NA-MR_03989
Description
This issue of Vital Signs, released on February 25, 2008, provides an strategic overview of issues, hurdles and challenges within the area of oral drug development. Additionally, a company spotlight is provided for Kosan Biosciences, a biotechnology company focused on developing and marketing innovative cancer therapies. Reimbursement and regulatory news from the FDA is also provided for the week of February 11 - February 15, 2008.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on February 25, 2008, provides an strategic overview of issues, hurdles and challenges within the area of oral drug development. Additionally, a company spotlight is provided for Kosan Biosciences, a biotechnology company focused on developing and marketing innovative cancer therapies. Reimbursement and regulatory news from the FDA is also provided for the week of February 11 - February 15, 2008.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 9561-00-56-00-00 |
| Is Prebook | No |